Argentina reaches intraocular lens milestone
This article was originally published in Clinica
Argentina implanted 2,200 intraocular lenses in the first seven months of 2008, under the centrally-funded national eyecare programme (PSO). Since its launch at the end of 2006, it has supplied around 6,000 lenses to the network of 61 hospitals that provide the surgery, according to the health ministry. The PSO, which features screening and early diagnosis initiatives, and guaranteed care (as set out in Resolution 1250/06), is responsible for supplying the surgical equipment, lenses and other consumables involved. The aim of the programme is to reduce the incidence of blindness, said to be preventable in 80% of cases, through treatment (60%) and screening and preventive care (20%).
You may also be interested in...
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.